Drug application
OMEPRAZOLE (OMEPRAZOLE)
Drugs@FDA ANDA 204012 · HETERO LABS LTD III
Key facts
| Drug name | OMEPRAZOLE |
|---|---|
| Active ingredients | OMEPRAZOLE |
| Application type | ANDA |
| Application number | 204012 |
| Company | HETERO LABS LTD III |
| Dosage forms | CAPSULE, DELAYED REL PELLETS, ORAL |
| Strength | 10MG |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Sep 26, 2019 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.